Message-ID: <33326876.1075861487782.JavaMail.evans@thyme> Date: Wed, 21 Nov 2001 05:01:14 -0800 (PST) From: alert@venturewire.com To: jdasovic@enron.com Subject: VentureWire Alert, Wednesday, November 21, 2001 Mime-Version: 1.0 Content-Type: text/plain; charset=us-ascii Content-Transfer-Encoding: 7bit X-From: VentureWire Alert X-To: jdasovic@ENRON.COM X-cc: X-bcc: X-Folder: \JDASOVIC (Non-Privileged)\Dasovich, Jeff\Deleted Items X-Origin: Dasovich-J X-FileName: JDASOVIC (Non-Privileged).pst VentureWire Alert
VentureWire Alert
 For Jeffrey Dasovich, Enron
VENTURE
MARKET
SUMMARY
Note to Readers: VentureWire newsletters will not be published on Thursday and Friday in observance of Thanksgiving. The next issue will be Monday, November 26.

As offices across the nation began to clear out for the Thanksgiving holiday, nine startups reported raising $58 million. The Brits may not be celebrating with turkey this week, but Netusability, a London-based provider of customer experience management technology and services, raised $4 million in its Series A round of funding, VentureWire learned. Past lead investor, eVerger, also led this round and was the sole investor.

VentureWire also reported that private equity firm Murphy & Partners is in the process of raising a third fund targeted for $125 million. The fund will invest in companies involved in the healthcare services, media, communications, and education sectors. If the luck of the Irish holds true, Murphy expects to have a first close by the end of first quarter or the beginning of second quarter 2002.

Optovation also had a reason to give thanks. The developer of advanced fiber optical modules said it raised $20 million in its Series B round of financing co-led by new investors, Altamira Investment Services and Newbury Ventures. Other participants included New Enterprise Associates, Redwood Ventures, Desjardins Venture Capital Group, and BMO Nesbitt Burns Equity Partners.

The complete text of the stories below, as well as 13 additional venture-capital and private-company stories, are available today exclusively to subscribers to our new, premium service, VentureWire Professional. Find out more.
Healthcare Outlook
San Francisco Airport Marriott
January 22, 2002

Healthcare OutlookDr. Michael Friedman
SVP, Research & Development,
Pharmacia Corp.


If it's an expert viewpoint from both sides of the regulatory divide you're looking for, Michael Friedman's superbly qualified to ask. A former acting commissioner of the FDA, and currently head of research at Pharmacia, he understands both the drug regulatory process and the pharmaceutical research and development process intimately. He bridges all the key areas on what it takes to get a drug through development and approval. On October 30th, it was announced that he will spearhead the Pharmaceutical Research and Manufacturers of America's (PhRMA) initiative to protect public health as PhRMA's Chief Medical Officer for Biomedical preparedness. Register your place today to hear his address at Healthcare Outlook




your account
•  Change your e-mail address
•  Thoughts, suggestions, commentary
•  Cancel your account
•  This newsletter was mailed to you at: jdasovic@ENRON.COM

contact
•  Send news items to: editor@venturewire.com
•  Send questions, complaints, or service queries to: help@venturewire.com
y•  Send advertising inquiries to: advertise@venturewire.com

Where to Find Follow-On Financing Now:

A VentureWire Special Report

Sure, venture money is harder to come by than ever,
but not impossible. In a Venture Wire Special Report
you can order today, we'll detail the investors who
have the capital, time, and willingness to fund
expansion rounds. You might be surprised: It's not
the usual suspects. Hundreds of young companies are
being funded every week -- not just seed rounds but
Series B, C, and even later -- and the VentureWire
Special report lists the seasoned investors who are
doing such deals outside their own portfolios.
These days, executive time is more precious than
ever; so don't waste it looking for money from VCs
who are fully invested, or engulfed with triage on
ailingn portfolios. Pitch the firms with plenty of
capital and a demonstrated recent willingness to
invest to help startups survive the downturn, and
thrive in the upturn. Order your VentureWire Special
Report now, and you'll get our real-time analysis of
today's money-raising environment, as well as the
list of key contacts inside the VC firms that are
the most active investors. The research, based on up-
to-the-minute reporting from VentureWire, will be
published next month. Reserve your copy today for the
discounted, pre-publication price of $365. (Price on
publication $495.) Send e-mail to
financing@venturewire.com and we'll send back complete
information and an order form.
NOTABLE DEALS

Murphy & Partners Raising New $125 Million PE Fund  mail 
NEW YORK -- Private equity firm Murphy & Partners is in the process of raising a third fund, targeted to close at $125 million, VentureWire has learned. [more..]
http://www.murphy-partners.com

Customer Management Firm Netusability Raises $4M Series A   mail 
SAN FRANCISCO -- Netusability, a London-based provider of customer experience management technology and services, raised $4 million in its Series A round of funding, VentureWire has learned. [more..]
http://www.netusability.com

Optical Module Firm Optovation Raises $20M Series B Round  mail 
OTTAWA -- Optovation, which develops advanced fiber optical modules, said it raised $20 million in its Series B round of financing. [more..]
http://www.optovation.com

Accenture Spin-out Indeliq Reduces Staff  mail 
CHICAGO -- Indeliq, which provides simulation-based e-learning applications to enterprises, has reduced its staff through an unspecified number of layoffs, according to director of corporate communications, Terrie Stengel. [more..]
http://www.indeliq.com

 advertise
 tell a friend

VENTUREWIRE INDEX VentureWire Index
453.9   -0.22%

Game Developer Nevrax Scores $6.2M in Additional Funding  mail 
PARIS -- Nevrax, which develops multiplayer, online role playing games, said it raised EUR 7 million ($6.2 million) in the second stage of its first financing round. [more..]
http://www.nevrax.com

Get2Chip Gets $11.5 Million in Series C Funds  mail 
SAN JOSE, CALIF. -- Get2Chip, an electronic design automation tools for system-on-a-chip synthesis, said it has raised $11.5 million in Series C funding, the second round of institutional financing for the firm. The round will close in a month. [more..]
http://www.get2chip.com

Ponte Communications Raises $7 Million Series C  mail 
MOUNTAIN VIEW, CALIF. -- Ponte Communications, a provider of software that enables companies and managed service providers to control network security policy across all devices, has raised $7 million in Series C financing, according to Charles Chi, general partner at Greylock, an investor in the company. [more..]
http://www.ponte.com


Healthcare Venture Capital Investing,
The Year In Review

What really happened to Healthcare investing in 2001?
Did the biotech miracle last? Did select e-health areas
take off? Which ones finally died? Where is the money
going and what are the trends for 2002? Healthcare is hot,
but selectively, and we know where and why. This year,
Healthcare Outlook will feature a special presentation by
Ken Andersen, Editor of VentureWire.
Ken will unveil the latest numbers across the healthcare
industry broken down by sector. You can wait until
late February and hear it with the rest of the world or get
the numbers first at Healthcare Outlook. Save your spot,
register today.

Healthcare Outlook, January 22, 2002
San Francisco Airport Marriott, Burlingame, Calif.

http://www.healthcareoutlook.com

ReturnBuy Cuts Warehouse and IT Development Staff  mail 
ASHBURN, VA. -- ReturnBuy.com, a provider of Web-based technology to process the reselling of returned and excess inventory, said it has laid off an undisclosed number of its warehouse and IT development staff to re-focus on its marketing and supply team. [more..]
http://www.returnbuy.com

MTS Health Makes $110 Million First Close on New Fund  mail 
NEW YORK -- MTS Health Partners, a private merchant bank providing equity capital and strategic advisory services to companies in the healthcare industry, said it made a $110 million first close on a new private equity fund. The firm also said Andrew M. Paul, former senior partner at Welsh Carson Anderson & Stowe, has been named chairman of the firm. [more..]
http://www.mtspartners.com


GET YOUR MIND AROUND IT

As a VentureWire reader, you know how many startups
are funded every day and how difficult it is to spot
the patterns in what's happening. ComputerLetter can
help. Written by analysts who have been following the
world of high technology for decades, ComputerLetter
is a lucid, literate guide to the trends behind
the latest technology.

For the must read that's also a good read, visit:
http://www.technologicpartners.com/tp/cl/default.html

To cancel, change, or update your subscription:
http://alert.venturewire.com/account.asp